0001209191-17-048136.txt : 20170808 0001209191-17-048136.hdr.sgml : 20170808 20170808173251 ACCESSION NUMBER: 0001209191-17-048136 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170804 FILED AS OF DATE: 20170808 DATE AS OF CHANGE: 20170808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roberts David B CENTRAL INDEX KEY: 0001365731 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 171015821 MAIL ADDRESS: STREET 1: 55 BRADFORD STREET CITY: NEEDHAM STATE: MA ZIP: 02492 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-04 0 0001158895 LEMAITRE VASCULAR INC LMAT 0001365731 Roberts David B C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 0 0 President and Director Common Stock 2017-08-04 4 M 0 1500 6.51 A 30105 D Common Stock 2017-08-04 4 M 0 21094 7.10 A 51199 D Common Stock 2017-08-04 4 M 0 25723 7.87 A 76922 D Common Stock 2017-08-04 4 S 0 48317 33.1205 D 28605 D Stock Option (Right to Buy) 6.51 2017-08-04 4 M 0 1500 0.00 D 2011-04-26 2018-04-26 Common Stock 1500 0 D Stock Option (Right to Buy) 7.10 2017-08-04 4 M 0 21094 0.00 D 2011-07-26 2018-07-26 Common Stock 21094 0 D Stock Option (Right to Buy) 7.87 2017-08-04 4 M 0 25723 0.00 D 2014-07-24 2021-07-24 Common Stock 25723 17149 D Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $32.70 to $33.54. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. This option is fully vested and exercisable. This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Laurie A. Churchill, Attorney-in-fact 2017-08-08